The aim of the present study was to evaluate Ki-67 and CD100 expression in STS patient samples from Barretos Cancer Hospital (Barretos, Brazil) to determine whether, in the current population sample, reproducible results of the markers as effective prognostic factors in STSs are obtained. The gene discussed is MKI67; the disease is cancer.